Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202
Go back to Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202| (NASDAQ: BCAB) | Delayed: 3.71 +0.09 (2.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.62 | 52 Week High | $ | |||
| Open | $3.59 | 52 Week Low | $ | |||
| Day High | $3.80 | P/E | N/A | |||
| Day Low | $3.59 | EPS | $ | |||
| Volume | 5,082 | |||||
| (NASDAQ: CNTX) | Delayed: 0.66 +0.03 (4.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.63 | 52 Week High | $ | |||
| Open | $0.60 | 52 Week Low | $ | |||
| Day High | $0.68 | P/E | N/A | |||
| Day Low | $0.59 | EPS | $ | |||
| Volume | 929,130 | |||||
